Xenopoulos, Panos
Cleveland Clinic · Queen Mary University of London · University of Cambridge · Central Texas Neurology Consultants
2 papers on CoChat
Most cited papers
- Verified
Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings
Coles, A. J., Cohen, J. A., Fox, E. J., Giovannoni, G., Hartung, H.-P., Havrdova, E., Schippling, S., Selmaj, K. W., Traboulsee, A., Compston, D. A. S., et al. (2017) · Neurology
Multiple Sclerosis Research StudiesPolyomavirus and related diseases
Cited by 277
- Verified
Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy
Havrdova, E., Arnold, D. L., Cohen, J. A., Hartung, H.-P., Fox, E. J., Giovannoni, G., Schippling, S., Selmaj, K. W., Traboulsee, A., Compston, D. A. S., et al. (2017) · Neurology
Multiple Sclerosis Research StudiesPolyomavirus and related diseases
Cited by 221
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free